Coeliac disease is a small bowel disease usually seen
in the jejunum. It is also known as gluten-sensitive enteropathy. It is an
immune reaction to the alpha-gliaden component of gluten resulting in mucosal
villous atrophy and loss of a large absorptive surface area in the small bowel.
It can occur at any age but is most obvious in children.
Celiac disease is more common in patients with Down
syndrome and type 1 diabetes, autoimmune thyroid disease, and in some racial
groups. Northern European and Celtic populations seem particularly susceptible.
This relates to the prevalence of HLA -DQ2 and 14 HLA-DQ8 genes in the
populations affected.
An individual without coeliac disease has a 10°/e risk
of the disease if it is present in a sibling or direct family member and is at
85°/c risk if it is in their identical twin. Gluten containing food should
ideally be withheld until 6 months of age to reduce the risk of disease.
Oral conditions such as aphthous ulcers, angular
cheilitis, recurrent herpetic, lesions, caries, enamel hypoplasia, atropic
glossitis and glossodynia are seen. Investigation involves testing for
antibodies in the blend. A positive test should lead to more specific tests for
anti-gliadin antibodies and antiendomysial antibodies. Positive results in
these are significant. Endoscopy with jejunal biopsy is the most accurate test,
but it is not usually performed unless there is evidence of growth failure
together with an antibody profile which suggests coeliac disease.
Treatment Involves avoiding gluten in the diet
completely which can enable proper functioning and reverse the adverse effects
of malabsorption in the small bowel. Other than diet care must be taken as some
lipsticks and medications can have gluten as fillers.